NUGX
NuGenerex Immuno-Oncology Inc

9
Loading...
Loading...
NuGenerex Immuno-Oncology, Inc. is an oncology company focuses on the modulation of the immune system to treat cancer. It develops immunotherapeutic products and vaccines based on proprietary, patented platform technology, Ii-Key. The Ii-Key is a peptide derived from the major histocompatibility complex (MHC) class II associated invariant chain that regulates the formation, trafficking, and antigen-presenting functions of MHC class II complexes, essential for the activation of T cells in the immune response. The company was founded on October 8, 1993 and is headquartered in Miramar, FL.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is the 52-week high for NuGenerex Immuno-Oncology Inc?
What is the 52-week low for NuGenerex Immuno-Oncology Inc?
What is NuGenerex Immuno-Oncology Inc stock price today?
What was NuGenerex Immuno-Oncology Inc stock price yesterday?
What is the 50-day moving average of NuGenerex Immuno-Oncology Inc?

Latest NUGX News

View
No NUGX news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.